Literature DB >> 26941370

Perspectives of Health-Care Providers Toward Advance Care Planning in Patients With Advanced Cancer and Congestive Heart Failure.

Manisha Chandar1, Bruce Brockstein1, Alan Zunamon1, Irwin Silverman1, Sarah Dlouhy1, Kathryn Ashlevitz1, Cory Tabachow1, Brittany Lapin1, Bernard Ewigman1, Theodore Mazzone1, Jennifer Obel1.   

Abstract

BACKGROUND: Advance care planning (ACP) discussions afford patients and physicians a chance to better understand patients' values and wishes regarding end-of-life care; however, these conversations typically take place late in the course of a disease. The goal of this study was to clarify attitudes of oncologists, cardiologists, and primary care physicians (PCPs) toward ACP and to identify persistent barriers to timely ACP discussion following a quality improvement initiative at our health system geared at improvement in ACP implementation.
METHODS: A 20-question, cross-sectional online survey was created and distributed to cardiologists, oncologists, PCPs, and cardiology and oncology support staff at the NorthShore University HealthSystem (NorthShore) from February to March 2015. A total of 117 individuals (46% of distributed) completed the surveys. The results were compiled using an online survey analysis tool (SurveyMonkey, Inc., Palo Alto, California, USA).
RESULTS: Only 15% of cardiologists felt it was their responsibility to conduct ACP discussions with their patients having congestive heart failure (CHF). In contrast, 68% of oncologists accepted this discussion as their responsibility in patients with terminal cancer ( P < .01). These views were mirrored by PCPs, as 68% of PCPs felt personally responsible for ACP discussion with patients having CHF, while only 34% felt the same about patients with cancer. Reported documentation of these discussions in the electronic health record was inconsistent between specialties. Among all surveyed specialties, lack of time was the major barrier limiting ACP discussion. Perceived patient discomfort and discomfort of the patient's family toward these discussions were also significant reported barriers.
CONCLUSION: Attitudes toward ACP implementation vary considerably by medical specialty and medical condition, with oncologists in this study tending to feel more personal responsibility for these discussions with patients having cancer than cardiologists with their patients having heart failure. Robust implementation of ACP across the spectrum of medical diagnoses is likely to require a true collaboration between office-based PCPs and specialists in both the inpatient and the ambulatory settings.

Entities:  

Keywords:  advance care planning; advanced cancer; congestive heart failure; end of life; physician perspectives; physician–patient discussion

Mesh:

Year:  2016        PMID: 26941370     DOI: 10.1177/1049909116636614

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  11 in total

1.  Advance Care Planning: Understanding Clinical Routines and Experiences of Interprofessional Team Members in Diverse Health Care Settings.

Authors:  Kelly Arnett; Rebecca L Sudore; David Nowels; Cindy X Feng; Cari R Levy; Hillary D Lum
Journal:  Am J Hosp Palliat Care       Date:  2016-09-06       Impact factor: 2.500

2.  Building an Infrastructure and Standard Methodology for Actively Engaging Patients in Advance Care Planning.

Authors:  Karen Stepan; Lara Bashoura; Marina George; Wendy Griffith; Margaret Meyer; Nico Nortjé; Kristen Price; Donna S Zhukovsky; Maria Alma Rodriguez
Journal:  J Oncol Pract       Date:  2019-10-10       Impact factor: 3.840

Review 3.  Using Implementation Science to Further the Adoption and Implementation of Advance Care Planning in Rural Primary Care.

Authors:  Heather Nelson-Brantley; Carol Buller; Christie Befort; Edward Ellerbeck; Ariel Shifter; Shellie Ellis
Journal:  J Nurs Scholarsh       Date:  2019-09-23       Impact factor: 3.176

4.  Completion of advance directives among African Americans and Whites adults.

Authors:  Mohsen Bazargan; Sharon Cobb; Shervin Assari
Journal:  Patient Educ Couns       Date:  2021-03-31

5.  Survey on German Palliative Care Specialists' Experiences with Advance Directives.

Authors:  Julia Zenz; Michael Zenz
Journal:  Pain Ther       Date:  2016-11-29

6.  Patient and clinician experience of a serious illness conversation guide in oncology: A descriptive analysis.

Authors:  Joanna Paladino; Luca Koritsanszky; Lauren Nisotel; Bridget A Neville; Kate Miller; Justin Sanders; Evan Benjamin; Erik Fromme; Susan Block; Rachelle Bernacki
Journal:  Cancer Med       Date:  2020-05-04       Impact factor: 4.452

7.  Advance Care Planning and End-Of-Life Communications: Practical Tips for Oncology Advanced Practitioners.

Authors:  Poonam Goswami
Journal:  J Adv Pract Oncol       Date:  2021-01-01

Review 8.  Disparities in Palliative and Hospice Care and Completion of Advance Care Planning and Directives Among Non-Hispanic Blacks: A Scoping Review of Recent Literature.

Authors:  Mohsen Bazargan; Shahrzad Bazargan-Hejazi
Journal:  Am J Hosp Palliat Care       Date:  2020-12-08       Impact factor: 2.500

9.  English and Spanish-speaking vulnerable older adults report many barriers to advance care planning.

Authors:  Linda H Phung; Deborah E Barnes; Aiesha M Volow; Brookelle H Li; Nikita R Shirsat; Rebecca L Sudore
Journal:  J Am Geriatr Soc       Date:  2021-06-01       Impact factor: 7.538

10.  Behavioral economic implementation strategies to improve serious illness communication between clinicians and high-risk patients with cancer: protocol for a cluster randomized pragmatic trial.

Authors:  Samuel U Takvorian; Justin Bekelman; Rinad S Beidas; Robert Schnoll; Alicia B W Clifton; Tasnim Salam; Peter Gabriel; E Paul Wileyto; Callie A Scott; David A Asch; Alison M Buttenheim; Katharine A Rendle; Krisda Chaiyachati; Rachel C Shelton; Sue Ware; Corey Chivers; Lynn M Schuchter; Pallavi Kumar; Lawrence N Shulman; Nina O'Connor; Adina Lieberman; Kelly Zentgraf; Ravi B Parikh
Journal:  Implement Sci       Date:  2021-09-25       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.